Arkolith/Insider Trading/ADAP/Form 4

Norry Elliot

Chief Medical OfficerAdaptimmune Therapeutics PLC (ADAP) · full profile →Form 4 · filed Jan 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2024Sell(S)8K$0.85$7K12K
Jan 11, 2024Sell(S)4K$0.84$3K6K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-003743) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML